May 30, 2019
Sysmex Inostics OncoBEAM(TM)-EGFR Digital PCR Liquid Biopsy Demonstrates Two-fold Higher Detection of p.T790M Mutations in 183 NSCLC Patients in Comparison Study
Nov 05, 2018
Sysmex Inostics OncoBEAM(TM) Circulating Tumor DNA Technology Demonstrates Superior Response Prediction for Advanced Pancreatic Cancer over Standard-of-care Protein Biomarkers
Oct 18, 2018
Sysmex Inostics' OncoBEAM(TM) Platform Demonstrates Superior Detection of Clinically-relevant Mutations for Therapy Selection and Molecular Monitoring for Lung and Colon Cancers
Oct 15, 2018
Sysmex Inostics' OncoBEAM(TM) Liquid Biopsy Technology Demonstrates Utility for Clinical Management of Melanoma Patients Undergoing Treatment With Targeted Therapy and Immune Checkpoint Inhibitors
Sep 28, 2018
Sysmex Inostics Announces Launch of OncoBEAMTM EGFR Kit v2 (RUO) in Europe and Asia
May 31, 2018
Clinical Evaluation of Sysmex Inostics' Plasma NGS Liquid Biopsy Technology to Complement Mammography When Screening for Early Stage Breast Cancer Presented at the 2018 ASCO Annual Meeting
Apr 13, 2018
Sysmex Inostics Expands OncoBEAM(TM) Liquid Biopsy Testing in the U.S. to Assist Clinicians and Patients
Apr 11, 2018
Sysmex Inostics: OncoBEAM(TM) RAS CRC Liquid Biopsy Test Now Reimbursed in Germany by BARMER
Jan 22, 2018
In Depth: Performance Comparison of OncoBEAM(TM) RAS CRC and Idylla(TM) ctKRAS Liquid Biopsy Testing for KRAS Mutation Detection Presented at ASCO GI 2018
Jan 17, 2018
Liquid Biopsy Performance Comparison of OncoBEAM RAS CRC and Idylla ctKRAS Testing Presented at ASCO GI 2018 Meeting
Nov 21, 2017
Expert Taskforce Recommendation of OncoBEAM(TM) RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients
Nov 15, 2017
New Research Reveals Molecular Heterogeneity of Metastatic Gastroesophageal Cancer